Package 0003-6120-01

{"route": ["SUBCUTANEOUS"], "spl_id": "63db7271-4d46-45d1-99b9-18821495ea77", "openfda": {"nui": ["N0000175531", "M0009499", "N0000191260", "N0000191259"], "unii": ["743QUY4VD8", "31YO63LBSN"], "rxcui": ["2700798", "2700805", "2728491", "2728492"], "spl_set_id": ["7f8c38fa-42f4-4387-9e8c-7a1c66855d8b"], "pharm_class_cs": ["Glycoside Hydrolases [CS]"], "pharm_class_epc": ["Endoglycosidase [EPC]", "Programmed Death Receptor-1 Blocking Antibody [EPC]"], "pharm_class_moa": ["Programmed Death Receptor-1-directed Antibody Interactions [MoA]"], "manufacturer_name": ["E.R. Squibb & Sons, L.L.C."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (0003-6120-01)  / 5 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "0003-6120-01", "marketing_start_date": "20250102"}], "brand_name": "OPDIVO QVANTIG", "product_id": "0003-6120_63db7271-4d46-45d1-99b9-18821495ea77", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Endoglycosidase [EPC]", "Glycoside Hydrolases [CS]", "Programmed Death Receptor-1 Blocking Antibody [EPC]", "Programmed Death Receptor-1-directed Antibody Interactions [MoA]"], "product_ndc": "0003-6120", "generic_name": "nivolumab and hyaluronidase-nvhy", "labeler_name": "E.R. Squibb & Sons, L.L.C.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "OPDIVO QVANTIG", "active_ingredients": [{"name": "HYALURONIDASE (HUMAN RECOMBINANT)", "strength": "2000 U/mL"}, {"name": "NIVOLUMAB", "strength": "120 mg/mL"}], "application_number": "BLA761381", "marketing_category": "BLA", "marketing_start_date": "20250102", "listing_expiration_date": "20261231"}